FDA Import Refusal 1FX-2700396-0/20002/2 — Daewoong Pharmaceutical, Co., Ltd.
The FDA refused shipment 1FX-2700396-0/20002/2 from Daewoong Pharmaceutical, Co., Ltd. (South Korea) on April 17, 2026. The refused product falls under Drugs and Biologics — ONABOTULINUMTOXINA. Cited charges: 118,3280,75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- April 17, 2026
- Country
- South Korea
- Product Category
- Drugs and Biologics
- Product Code
- 58PIZ05 ONABOTULINUMTOXINA
- Charges
- 118,3280,75